Medtronic

NYSE: MDT · Real-Time Price · USD
92.90
0.92 (1.00%)
At close: Aug 15, 2025, 3:10 PM

Medtronic Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020
Revenue
33.54B 33.2B 33B 32.58B 32.36B 32.32B 31.96B 31.56B 31.23B 30.77B 30.81B 31.07B 31.69B 31.79B 31.8B 31.6B 30.12B 27.93B 27.87B 27.93B
Cost of Revenue
11.63B 11.53B 11.53B 11.35B 11.21B 11.15B 11.06B 10.83B 10.72B 10.33B 10.1B 10.06B 10.14B 10.21B 10.37B 10.58B 10.48B 10.1B 9.87B 9.56B
Gross Profit
21.9B 21.67B 21.46B 21.23B 21.15B 21.17B 20.9B 20.73B 20.51B 20.44B 20.71B 21.01B 21.54B 21.58B 21.43B 21.02B 19.63B 17.83B 17.99B 18.36B
Operating Income
5.96B 5.57B 5.41B 5.15B 5.14B 5.66B 5.57B 5.63B 5.49B 5.59B 5.86B 6.02B 5.75B 5.69B 5.3B 4.67B 4.49B 3.2B 3.56B 3.98B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
5.63B 5.22B 5.16B 4.91B 4.84B 5.53B 5.43B 5.52B 5.37B 5.42B 5.63B 5.73B 5.52B 5.48B 5.11B 4.14B 3.9B 2.53B 2.89B 3.66B
Net Income
4.66B 4.26B 4.29B 3.93B 3.68B 4.2B 4.1B 3.62B 3.76B 4.06B 4.32B 5.21B 5.04B 4.92B 4.71B 3.88B 3.61B 2.89B 3.54B 4.41B
Selling & General & Admin
10.85B 10.89B 10.85B 10.78B 10.74B 10.59B 10.53B 10.46B 10.41B 10.37B 10.31B 10.31B 10.29B 10.32B 10.29B 10.28B 10.15B 9.91B 9.96B 9.98B
Research & Development
2.73B 2.72B 2.74B 2.74B 2.74B 2.7B 2.69B 2.67B 2.69B 2.71B 2.68B 2.68B 2.73B 2.71B 2.66B 2.62B 2.49B 2.43B 2.4B 2.36B
Other Expenses
2.37B 2.48B 2.46B 2.55B 2.53B 2.22B 2.11B 1.97B 1.91B 1.77B 1.85B 1.99B 2.75B 2.85B 3.17B 3.45B 2.51B 2.29B 2.07B 2.04B
Operating Expenses
15.95B 16.1B 16.05B 16.07B 16B 15.51B 15.34B 15.1B 15.02B 14.85B 14.85B 14.99B 15.79B 15.89B 16.12B 16.35B 15.15B 14.63B 14.44B 14.38B
Interest Expense
729M 757M 766M 737M 718M 703M 682M 620M 636M 592M 562M 580M 553M 552M 558M 892M 926M 946M 959M 654M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
27.58B 27.63B 27.59B 27.42B 27.22B 26.66B 26.39B 25.93B 25.74B 25.18B 24.95B 25.05B 25.93B 26.1B 26.49B 26.93B 25.63B 24.73B 24.31B 23.95B
Income Tax Expense
937M 935M 833M 954M 1.13B 1.3B 1.31B 1.87B 1.58B 1.33B 1.29B 504M 456M 546M 381M 236M 265M -369M -650M -758M
Shares Outstanding (Basic)
1.28B 1.28B 1.28B 1.29B 1.32B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.34B 1.34B 1.35B 1.34B 1.35B 1.35B 1.34B 1.34B
Shares Outstanding (Diluted)
1.29B 1.29B 1.29B 1.3B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.33B 1.34B 1.35B 1.36B 1.36B 1.36B 1.36B 1.35B 1.35B
EPS (Basic)
3.63 3.30 3.28 2.97 2.75 3.15 3.08 2.72 2.83 3.05 3.23 3.88 3.75 3.65 3.49 2.88 2.67 2.14 2.63 3.29
EPS (Diluted)
3.62 3.29 3.27 2.96 2.75 3.14 3.07 2.71 2.82 3.04 3.22 3.87 3.73 3.63 3.47 2.86 2.66 2.14 2.62 3.27
EBITDA
9.22B 8.65B 8.56B 8.28B 8.2B 8.91B 8.82B 8.84B 8.7B 8.71B 8.89B 9.01B 8.78B 8.74B 8.38B 7.74B 7.52B 6.17B 6.53B 6.99B
EBIT
6.36B 5.98B 5.92B 5.64B 5.55B 6.24B 6.12B 6.14B 6B 6.01B 6.19B 6.31B 6.07B 6.03B 5.67B 5.04B 4.82B 3.48B 3.85B 4.32B
Depreciation & Amortization
2.86B 2.67B 2.64B 2.64B 2.65B 2.67B 2.7B 2.7B 2.7B 2.71B 2.7B 2.7B 2.71B 2.7B 2.71B 2.7B 2.7B 2.69B 2.67B 2.67B